clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Ultra-Low Energy MRI Shows Its Potential
News & Features
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Informatics
DeepMind’s Next-Gen Protein Structure Predictor AlphaFold 3 Released
News & Features
AI Improves Prostate Cancer Recurrence Prediction
News & Features
Targeting Iron Uptake Shows Promise for Treating Asthma and Other Allergic…
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Foundation Medicine, Caris Assays Identify Patients for NCI-MATCH
Clinical trial
Molecular Dx
Foundation Medicine, Caris Assays Identify Patients for NCI-MATCH
Inside Precision Medicine Staff Writer
-
June 9, 2017
0
News & Features
Seattle Children’s Launches Personalized Medicine Trial Focused on IBD, GVHD
Inside Precision Medicine Staff Writer
-
May 23, 2017
0
Molecular Dx
A Proper MATCH: New NGS Method Up to Snuff for Tumor Analysis in NCI-MATCH Clinical Trial
Inside Precision Medicine Staff Writer
-
March 24, 2017
0
News & Features
Clinical OMICs Magazine Volume 4, Issue No. 2
Inside Precision Medicine Staff Writer
-
March 20, 2017
0
Molecular Dx
Natera Signs on to I-SPY 2 TRIAL For Breast Cancer Clinical Trial
Inside Precision Medicine Staff Writer
-
December 15, 2016
0
News & Features
Clinical OMICs Magazine Volume 3, Issue No. 6
Inside Precision Medicine Staff Writer
-
June 1, 2016
0
Molecular Dx
Exome Sequencing Beginning to Displace Common Genetic Tests in Clinic
Inside Precision Medicine Staff Writer
-
April 6, 2016
0
News & Features
Clinical OMICs Magazine Volume 3, Issue No. 4
Inside Precision Medicine Staff Writer
-
April 1, 2016
0
News & Features
Clinical OMICs Magazine Volume 2, Issue No. 5
Inside Precision Medicine Staff Writer
-
May 1, 2015
0
News & Features
Clinical OMICs Magazine Volume 1, Issue No. 14
Inside Precision Medicine Staff Writer
-
November 19, 2014
0
1
...
58
59
60
Page 59 of 60
Related Content
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Patients of New Doctors with High Board Certification Scores Have Higher Survival Rates
Patient Adverse Events Prevalent in Outpatient Settings
New Vaccine Approach Offers Protection from Coronaviruses That Haven’t Yet Emerged
Inside Precision Medicine
![Tumor profiling assays of Foundation Medicine and Caris Life Sciences will identify abnormalities qualifying a patient for personalized cancer treatment through NCI-MATCH. [Royalty Stock Photo/Shutterstock]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1125.jpeg "Foundation Medicine, Caris Assays Identify Patients for NCI-MATCH")
